Changes in Chromosome Counts and Patterns in CHO Cell Lines upon Generation of Recombinant Cell Lines and Subcloning

Changes in Chromosome Counts and Patterns in CHO Cell Lines upon Generation of Recombinant Cell... IntroductionMammalian‐based expression systems make up more than 60% of the biopharmaceutical market, with sales exceeding 140 billion dollars in 2013. Among these systems, Chinese hamster ovary (CHO) cells account for the majority of approved products and are state of the art for the production of recombinant protein therapeutics. Large and complex‐structured biologics require human‐like post‐translational modifications in order to be non‐immunogenic and functional, a feature that is adequately fulfilled by CHO cells. On the downside, CHO cells, like all rapidly growing and immortalized cell lines, are genomically unstable, intraclonally heterogeneous, and frequently undergo genotypic variations. These lead to phenotypic instability and hence problems with respect to process reproducibility or production instability. As a consequence of such genotypic drifts, CHO cells are quasi‐diploid with a chromosome number that diverges from that of the primary Chinese hamster and with different karyotypes and modal chromosome numbers for each cell line analyzed.To overcome the heterogenic nature of CHO cells, a lot of effort is put into clone and cell line development in order to obtain a clonal cell line with advantageous growth, productivity, and stable properties. The requirement for clonality is based on the assumption that subclones are phenotypically and genetically homogenous and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biotechnology Journal Wiley

Changes in Chromosome Counts and Patterns in CHO Cell Lines upon Generation of Recombinant Cell Lines and Subcloning

Loading next page...
 
/lp/wiley/changes-in-chromosome-counts-and-patterns-in-cho-cell-lines-upon-Wktu7Gp0wU
Publisher
Wiley
Copyright
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
ISSN
1860-6768
eISSN
1860-7314
D.O.I.
10.1002/biot.201700495
Publisher site
See Article on Publisher Site

Abstract

IntroductionMammalian‐based expression systems make up more than 60% of the biopharmaceutical market, with sales exceeding 140 billion dollars in 2013. Among these systems, Chinese hamster ovary (CHO) cells account for the majority of approved products and are state of the art for the production of recombinant protein therapeutics. Large and complex‐structured biologics require human‐like post‐translational modifications in order to be non‐immunogenic and functional, a feature that is adequately fulfilled by CHO cells. On the downside, CHO cells, like all rapidly growing and immortalized cell lines, are genomically unstable, intraclonally heterogeneous, and frequently undergo genotypic variations. These lead to phenotypic instability and hence problems with respect to process reproducibility or production instability. As a consequence of such genotypic drifts, CHO cells are quasi‐diploid with a chromosome number that diverges from that of the primary Chinese hamster and with different karyotypes and modal chromosome numbers for each cell line analyzed.To overcome the heterogenic nature of CHO cells, a lot of effort is put into clone and cell line development in order to obtain a clonal cell line with advantageous growth, productivity, and stable properties. The requirement for clonality is based on the assumption that subclones are phenotypically and genetically homogenous and

Journal

Biotechnology JournalWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off